E-cadherin/Aurora A kinase inhibitor synthetic lethality in breast cancer
Cell Reports · 2026-12 · 45 (12) · 118366
DOI: 10.1016/j.celrep.2026.118366 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026-12. Verfasst von William W. Yang und 21 weiteren Autor:innen. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Breast Cancer Now.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Breast Cancer Now
Zitieren
APA
Yang, W. W., Brough, R., Song, F., Konde, A., Lai, Q. T., Scrimgeour, R., Betteridge, K., Roumeliotis, T. I., Choudhary, J., Flaherty, R., Pezot, S., Nicholas, A. A., Guppy, N., Starling, C., Meehan, S., Roxanis, I., Fitzpatrick, A., Brisken, C., Isacke, C., …, & Lord, C. J. (2026). E-cadherin/Aurora A kinase inhibitor synthetic lethality in breast cancer. Cell Reports, 45(12), 118366. https://doi.org/10.1016/j.celrep.2026.118366
Vancouver
Yang WW, Brough R, Song F, Konde A, Lai QT, Scrimgeour R, et al. E-cadherin/Aurora A kinase inhibitor synthetic lethality in breast cancer. Cell Reports. 2026;45(12):118366. doi:10.1016/j.celrep.2026.118366
BibTeX
@article{Yang2026,
author = {Yang, William W. and Brough, Rachel and Song, Feifei and Konde, Asha and Lai, Queenie T.K. and Scrimgeour, Ross and Betteridge, Kai and Roumeliotis, Theodoros I. and Choudhary, Jyoti and Flaherty, Renee and Pezot, Solene and Nicholas, Anya A. and Guppy, Naomi and Starling, Chris and Meehan, Sarah and Roxanis, Ioannis and Fitzpatrick, Amanda and Brisken, Cathrin and Isacke, Clare and Pettitt, Stephen J. and Tutt, Andrew N.J. and Lord, Christopher J.},
title = {E-cadherin/Aurora A kinase inhibitor synthetic lethality in breast cancer},
journal = {Cell Reports},
year = {2026},
volume = {45},
number = {12},
pages = {118366},
doi = {10.1016/j.celrep.2026.118366}
}
EUVIMED